BidSonarBidSonar
ContractsGrantsOrganisationsSectors
BidSonarBidSonar·Built by Hypership
SourcesBrandPrivacyTermsCookies

BidSonar is an independent index of public-sector opportunities. We aggregate data from official sources and are not affiliated with any procurement body. Data is licensed under the Open Government Licence v3.0 and the EU TED reuse notice.

    ContractsGermany – Pharmaceutical Discount Contracts Starting November 1, 2024
    Closed contract

    Germany – Pharmaceutical Discount Contracts Starting November 1, 2024

    Tender closed
    1 Sept 2026
    7 weeks ago

    This contract opportunity involves the establishment of discount contracts for various pharmaceutical substances under the Open-House procedure, as per § 130a Abs. 8 SGB V. All eligible and interested pharmaceutical companies or consortia are invited to enter into discount contracts for the followin

    🇩🇪GermanyPublished 28 Oct 2025· 11 months agoviaTED
    Tender closed
    1 Sept 2026
    7 weeks ago
    Tender deadline passed on 1 Sept 2026.

    Decision brief

    4 fields
    • Contract value
      Not disclosed
      Source did not declare a figure
    • Tender closed
      1 Sept 2026
      1 months ago
    • Sector
      Healthcare & Medical
      Browse related listings
    • Location
      🇩🇪Germany

    Lifecycle

    Closed

    Tender closed on 1 Sept 2026. Awaiting award.

    28 Oct 2025Today1 Sept 2026

    Brief

    This contract opportunity involves the establishment of discount contracts for various pharmaceutical substances under the Open-House procedure, as per § 130a Abs. 8 SGB V. All eligible and interested pharmaceutical companies or consortia are invited to enter into discount contracts for the following substances: Benralizumab, Bosutinib, Brimonidine & Brinzolamid, Calcium Carbonate & Colecalciferol, Certolizumab, Dexamethasone (only IMP), Etanercept, Golimumab, Lopinavir & Ritonavir, Multienzyme, Paliperidone (excluding depot injection suspension for 1-month dosage), Ritonavir, Tacrolimus, Tezepelumab, Vilanterol & Umeclidinium & Fluticasone furoate, and Vildagliptin. The earliest contract start date is November 1, 2024, with a maximum contract duration of 24 months.

    More from AOK NORDWEST

    2 listingsView all →
    Healthcare & Medical🇩🇪Germany

    Pharmaceutical Discount Contracts in Germany Starting January 1, 2026

    This contract opportunity involves the establishment of discount contracts for various active ingredients under the Open-House procedure, as per § 130a Abs. 8 SGB V. All eligible and interested pharmaceutical companies or consortia are invited to enter into discount contracts under uniform terms and

    AOK NORDWEST
    Published 10 Nov 2025
    Healthcare & Medical🇩🇪Germany

    Germany – Supply Contracts for Medical Dressings Starting August 1, 2025

    This announcement is for the establishment of contracts to supply medical dressings to the insured members of AOK NW, in accordance with § 31 SGB V, through an Open-House procedure. All qualified and interested service providers are invited to enter into this contract under uniform contractual condi

    AOK NORDWEST
    Published 19 Jun 2025

    Open in Healthcare & Medical

    4 open listingsView all →
    Healthcare & Medical🇬🇧United Kingdom

    Medical Countermeasures for Chemical, Biological, Radiological and Nuclear (CBRN) Threats - R&D Funding

    Develop medical countermeasures for CBRN threats with up to £4 million funding over 30 months, from prototype through Phase 2a clinical studies.

    est.£4,000,000
    Published 5 Nov 2026
    Healthcare & Medical🇬🇧United Kingdom

    Clinical Research Training Fellowship for Healthcare Professionals

    A three-year funded fellowship helping healthcare professionals with PhDs return to clinical research after extended career breaks.

    Medical Research Council (MRC)
    Published 21 Oct 2026
    Healthcare & Medical🇬🇧United Kingdom

    Digital Mental Health Service for Children and Young People in South Staffordshire

    Opportunity to provide a digital mental health platform delivering NICE-recommended therapeutic interventions and resources for children, young people, and families in South Staffordshire.

    MIDLANDS PARTNERSHIP FOUNDATION TRUST
    Published 16 Oct 2026
    OpenHealthcare & Medical🇬🇧United Kingdom

    Primary Care Network COPD Risk Stratification and Specialist Support Service

    Opportunity for Primary Care Networks to deliver integrated COPD identification and specialist support services using digital risk stratification across Hull and East Yorkshire communities.

    £22,200indicativeHULL UNIVERSITY TEACHING HOSPITALS NHS TRUST
    Published 16 Oct 2026
    Take action
    View on sourceTED

    Original closed notice on the publisher's site

    Publisher
    Publications Office of the European Union
    Licence
    EU 2011/833/EU + TED reuse notice
    Source
    ted.europa.eu
    Record ID
    713898-2025

    Your fit

    Could you win the next one?

    This one has closed. Sonar reads AOK NORDWEST's work like this against your business and sends the next one that fits, every Monday.

    Check my fit

    Free · Matches every Monday

    AN
    Buyer
    AOK NORDWEST
    Sector
    Healthcare & Medical